Theranos, Inc. announced that engineering and biomedical device design experts have joined the company’s newly created Technology Advisory Board (TAB).
Riley Bechtel Retires from Board; Company to Retire Board of Counselors Structure in Consolidation of Advisory Framework
Theranos Unveils Its Diagnostic-Testing Technologies at American Association for Clinical Chemistry Meeting
Theranos outlines research and development technologies to miniaturize analytical testing equipment.
Theranos also is creating a Compliance and Quality Committee, headed by newly appointed member of Board of Directors
Theranos responds to the CMS's recent notice of sanctions.
Dr. Fabrizio Bonanni and Dr. William H. Foege are among the new additions to the Theranos Board of the Directors.